For higher-risk patients, the guidance suggests targeted mitigation strategies
Three amino acid-altering GIP receptor variants (R190Q, E288G, and E354Q) are all associated with lower bone mineral density, and in postmenopausal women followed for 10 years, who were homozygous carriers of the E354Q variant, showed a higher risk of non-vertebral fractures (99, 101)
We focus on their latent applications in conditions including psoriasis, inflammatory bowel disease (IBD), rheumatoid arthritis (RA), asthma, multiple sclerosis (MS), Sjgrens syndrome (SS), and systemic lupus erythematosus (SLE), highlighting the broader therapeutic benefits of GLP-1RAs beyond their well-established use in managing T2DM and obesity
As a strong antioxidant, vitamin E helps keep cells and tissues safe from the damage caused by oxidative stress (48)